ACell , Inc.

Industry:	Pharmaceuticals, Biotechnology
Revenues:	Under $20 Million
Employees:	Under 99

Description

ACell Inc. is a regenerative medicine company that develops, manufactures, and markets products for medical and veterinary applications. Based on naturally occurring biological scaffolds, the tissue-engineered products produced by ACell change the fundamental healing response by encouraging the body's own regenerative capabilities to repair tissues and restore them to natural health.

The company's technology can dramatically increase the breadth of treatment options for disease and injuries and has applicability in a wide variety of treatments including wound care, surgery, orthopedics, dermatology, and cardiovascular medicine. ACell markets, distributes, and sells its products both directly and through strategic partners.

View More Statistics

Site Statistics

Monthly Unique Visitors:	653
Site Rank:	1,683,736
Trust Rating:	Neutral
Stats by

News Archive

ACell's CEO to Present at Rodman & Renshaw's 2009 Annual Global Investment Conference.(Conference news) Journal of Technology; 9/15/2009 ACell, Inc. is announcing its participation at...Investors and strategic partners interested in ACell's proprietary technology are encouraged...s presentation will provide an update on ACell's regenerative medicine technology and... ...more

ACell's CEO to Present at Rodman & Renshaw's 2009 Annual Global Investment Conference. PR Newswire; 9/2/2009 ...COLUMBIA, Md., Sept. 2 /PRNewswire/ -- ACell, Inc. is announcing its participation...Investors and strategic partners interested in ACell's proprietary technology are encouraged...presentation will provide an update on ACell's regenerative medicine technology and... ...more

Patent No. 7,543,416 Issued on June 9, Assigned to Acell Holdings for Glazed Panels Production Method (British Inventor) US Fed News Service, Including US State News; 8/4/2009 ...producing of glazed panels. The inventor was issued U.S. Patent No. 7,543,416 on June 9. The patent has been assigned to Acell Holdings Ltd., Guernsey, Great Britain. According to the abstract released by the U.S. Patent & Trademark Office... ...more